Digital cognitive check after a stroke in people with severe disability

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults with MCA stroke and a modified Rankin Scale score of 3 or higher to monitor cognitive recovery over time. It uses the TuCAN-App to perform multi-domain digital cognitive testing during the acute phase and at 3 and 6 months after the stroke. The aim is to standardize and rapidly assess cognitive function as patients progress, to understand recovery trajectories. Participation involves longitudinal assessments with informed consent provided by patients or their representatives. The study is led by University Hospital Tuebingen, with the Sigrid Oergel Foundation as a collaborator.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥ 18 years of age
* Right- or left-hemispheric MCA occlusion (MCA segments M1-M3 or corresponding perfusion deficit)
* modified Rankin Scale (mRS) score ≥ 3 at the time of the index event
* Informed consent from the patient or their legal representative

Exclusion Criteria:

* ≤ 18 years of age
* Pregnancy
* Pre-existing severe dementia

Where it's running

• Department of Neurology; University Hospital
  Tübingen, Germany Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multi-peptide Vaccination and PSMAxCD3 Antibody Therapy for Prostate Cancer with Biochemical Recurrence

  This phase 2 trial tests whether a PSMA-targeted bispecific antibody (CC-1), a prostate cancer peptide vaccine (VAC-XS15-PC01), or both can be given safely and help control biochemical recurrence after local therapy in men with prostate cancer.

  Recruiting Phase 2 University Hospital Tuebingen · Heidelberg, Baden-Wurttemberg and 3 other locations · NCT07860047

• Detecting cardiac amyloidosis in people with severe aortic valve narrowing

  This study tests non-invasively whether imaging tests can find heart amyloidosis in patients with severe aortic stenosis who are being evaluated for valve replacement.

  Recruiting University Hospital Tuebingen · Tübingen · NCT07752732

• Low-thermal Argon Plasma Devitalization for CIN2 Treatment

  This study tests whether a low-thermal argon plasma treatment can heal CIN2 on the cervix better than a sham procedure or active surveillance in women aged 18–40.

  Recruiting University Hospital Tuebingen · Tübingen, Baden-Wurttemberg · NCT07730645

• Real-time AI detection of surgical smoke during endoscopic laparoscopic procedures

  This pilot will test whether an AI system can detect surgical smoke in real time from endoscopic video during laparoscopic procedures that use high-frequency surgical devices.

  Recruiting University Hospital Tuebingen · Tübingen · NCT07397000

• Comparing open and robot-assisted removal of groin lymph nodes for penile cancer

  This trial will test whether robot-assisted groin lymph node removal causes fewer complications and faster recovery than standard open surgery for men with penile squamous cell carcinoma who need lymphadenectomy.

  Recruiting at 8 sites University Hospital Tuebingen · Berlin and 8 other locations · NCT07378670

• Preserving the rectum with higher-dose MRI-guided adaptive radiotherapy

  This tests whether higher-dose MRI-guided adaptive radiotherapy with standard chemotherapy can help people with distal rectal cancer keep their rectum.

  Recruiting Phase 2 University Hospital Tuebingen · Tübingen, Baden-Wurttemberg · NCT07337876

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.